Dr Rachel Errington
Prosiectau fel Prif Ymchwiliwr
1 o 3
- BH3 profiling to predict responses to drug treatment (01.08.2015 - 31.08.2016)
- Bridging the gaps in the imaging of patient derived cells for phenotyping and drug screening (01.09.2016 - 30.06.2017)
- Cell-based assay evaluation (01.06.2011 - 31.12.2012)
- Cellular informatics - enabling the interoperability of cytometric data: A novel bioinformatics approach for revealing systems level understanding of cell cycle dynamics (01.04.2010 - 31.10.2012)
- Deconvolving of dynamic cell cycle parameters from flow cytometry data. (01.06.2009 - 31.05.2010)
Prosiectau fel Cyd-Ymchwiliwr
1 o 4
- Applications of coherent anti-Stokes Raman scattering (CARS) microscopy to cell biology (02.07.2012 - 05.05.2015)
- Antimicrobial composite gels to prevent infection triggered failure of dental restorations (01.10.2017 - 31.08.2018)
- Building IT to support data-integration of genomic, imaging, and biobanking samples with clinical and population health data, to support cancer & genetic disease research for practical healthcare benefit in Wales (01.06.2020 - 28.02.2023)
- Cell painting to patients - Developing novel bio-imaging tools for standardisation and reproducibility of AI-assisted image analysis (01.11.2022 - 31.03.2023)
- Collaborative Development of Super-Resolution Imaging Methods for Profiling Extracellular Vesicle Heterogeneity with Single-Vesicle Resolution (01.10.2022 - 31.03.2023)
Thomson Reuters Deutschland GmbH
Zur Giesserei 2
D-76227 Karlsruhe | Germany